Friday, November 06, 2009

Saudi Arabia Orders 10,000,000 Doses of GSK's Pandemrix™

Another territory to add to the vaccine mix. The Saudi Food and Drug Authority (SFDA) has approved GlaxoSmithKline’s Pandemrix™ vaccine for the H1N1 flu virus on November 3, 2009, as the kingdom prepares to receive more than two million pilgrims at next month’s Haj. Unless GSK is making up a special batch for Saudi Arabia, the Pandemrix will probably have the same ingredients as it does in the United Kingdom, such as thimerosal.

You can read the Pandemrix™ package insert by clicking this sentence

“The authority ... has been following through all the phases of the production of the A (H1N1) flu vaccine by several international companies specialised in vaccines,” the SFDA said in a statement posted on its website.

The authority added that it decided to register GlaxoSmithKline’s vaccine, which is distributed under the Pandemrix brand name.

Saudi Arabia will begin a national vaccination campaign on Saturday, he said. The kingdom has a population of nearly 25 million, nearly a third of whom are expatriates. Priority will be given to pilgrims and hospital staff, health ministry spokesman Khaled Mirghalani said.

Remixx World! has previously documented the Pandemrix™ vaccine in the article GlaxoSmithKline's Pandemrix Approved for Use in the United Kingdom (Ingredients Include Squalene, Thimerosal and H1N1).

Some information even shows Pandemrix having a Regulatory/Status Index of "EU666" among many other indices. You can read a previous blog article (List of US666 & EU666 Vaccine Biodefense Stockpile Products in US & Europe (Including Prepandrix)!) on the US666 and EU666 Regulatory/Status Index designations by clicking the article link.

Source: The Qatar Peninsula

No comments: